Hood River Capital Management LLC Crinetics Pharmaceuticals, Inc. Transaction History
Hood River Capital Management LLC
- $5.79 Billion
- Q4 2024
A detailed history of Hood River Capital Management LLC transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Hood River Capital Management LLC holds 851,400 shares of CRNX stock, worth $28.9 Million. This represents 0.75% of its overall portfolio holdings.
Number of Shares
851,400
Previous 834,912
1.97%
Holding current value
$28.9 Million
Previous $42.6 Million
2.08%
% of portfolio
0.75%
Previous 0.79%
Shares
3 transactions
Others Institutions Holding CRNX
# of Institutions
255Shares Held
89.5MCall Options Held
26.1KPut Options Held
11.8K-
Vanguard Group Inc Valley Forge, PA9.09MShares$309 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA6.95MShares$236 Million0.07% of portfolio
-
Black Rock Inc. New York, NY6.23MShares$212 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.14MShares$208 Million3.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.41MShares$184 Million0.03% of portfolio
About Crinetics Pharmaceuticals, Inc.
- Ticker CRNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,752,800
- Market Cap $1.82B
- Description
- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...